Author Archives:

A Certificate of Analysis (COA) is the single most important document in research peptide sourcing. It is an independent laboratory report that documents a specific production batch’s measured purity, confirmed molecular identity, and physical characteristics. Without it, you have no objective way to know what is actually in the vial — making it the first […]

The nootropics research category covers a structurally diverse set of compounds sharing a common area of investigation: modulation of cognitive function, neuroprotection, and neurochemical signalling. For Australian researchers sourcing nootropic compounds, understanding the distinct mechanisms of the four most-studied classes — the classical racetam family, Noopept, and the synthetic peptide nootropics Semax and Selank — […]

GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Unlike many research peptides that are entirely synthetic constructs, GHK-Cu is endogenously present in the human body — with plasma concentrations declining significantly with age, prompting research interest in its role in tissue maintenance, wound healing, and skin biology. This […]

TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (Tβ4), a naturally occurring protein found in virtually all human and animal cells. While Thymosin Beta-4 is a 44-amino-acid protein, TB-500 corresponds to its core actin-binding domain — the sequence responsible for many of Tβ4’s most studied biological activities. For Australian researchers sourcing tissue-repair reference […]

Correct storage is one of the most overlooked variables in peptide research. Even a ≥99% purity compound can degrade rapidly if handled or stored incorrectly — potentially invalidating experimental results without any obvious visual cue. This guide covers the core storage science for lyophilised and reconstituted research peptides, with practical protocols for Australian laboratory researchers. […]

Selective Androgen Receptor Modulators (SARMs) are a class of synthetic ligands designed to bind the androgen receptor (AR) with tissue-selective activity. Of the many SARMs under investigation, three have accumulated the most substantial preclinical and early clinical research datasets: RAD-140 (Testolone), LGD-4033 (Ligandrol), and Ostarine (MK-2866). This article provides a structured research comparison of their […]

The incretin peptide research field has shifted significantly with the emergence of dual-agonist compounds. Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, has attracted substantial research attention following multiple head-to-head comparisons with semaglutide — the established selective GLP-1 receptor agonist. For researchers sourcing GLP-1 class compounds in Australia, understanding the mechanistic differences […]

BPC-157 (Body Protection Compound 157) has become one of the most extensively studied synthetic peptides in preclinical research, with over 100 peer-reviewed studies examining its biological activity across multiple physiological systems. For Australian researchers sourcing reference-grade peptides, understanding the science behind BPC-157 is essential context for experimental design and compound selection. This article provides a […]